PET Oncological Radiopharmaceuticals: Current Status and Perspectives is a research paper published in Molecules (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: U24CA220325
NIH
Grant: R01CA239694
NIH
Grant: P50CA236733
NIH
Grant: RR200046
NIH HHS
Grant: U24CA220325, R01CA239694, P50CA236733
National Institutes of Health
Grant: 5R01CA239694-05
Quantitative PET Imaging of Hepatocellular Carcinoma (HCC)
National Institutes of Health
Grant: 1U24CA220325-01A1
VU PREDICT
National Institutes of Health
Grant: 5P50CA236733-04
Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer
FWCI
0.84
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals